293 related articles for article (PubMed ID: 22421737)
1. Cardiac remodeling is not modulated by overexpression of muscle LIM protein (MLP).
Kuhn C; Frank D; Dierck F; Oehl U; Krebs J; Will R; Lehmann LH; Backs J; Katus HA; Frey N
Basic Res Cardiol; 2012 May; 107(3):262. PubMed ID: 22421737
[TBL] [Abstract][Full Text] [Related]
2. SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation.
Tang X; Pan L; Zhao S; Dai F; Chao M; Jiang H; Li X; Lin Z; Huang Z; Meng G; Wang C; Chen C; Liu J; Wang X; Ferro A; Wang H; Chen H; Gao Y; Lu Q; Xie L; Han Y; Ji Y
Circulation; 2020 Mar; 141(12):984-1000. PubMed ID: 31902237
[TBL] [Abstract][Full Text] [Related]
3. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
4. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
5. Downregulation and nuclear relocation of MLP during the progression of right ventricular hypertrophy induced by chronic pressure overload.
Ecarnot-Laubriet A; De Luca K; Vandroux D; Moisant M; Bernard C; Assem M; Rochette L; Teyssier JR
J Mol Cell Cardiol; 2000 Dec; 32(12):2385-95. PubMed ID: 11113014
[TBL] [Abstract][Full Text] [Related]
6. A common MLP (muscle LIM protein) variant is associated with cardiomyopathy.
Knöll R; Kostin S; Klede S; Savvatis K; Klinge L; Stehle I; Gunkel S; Kötter S; Babicz K; Sohns M; Miocic S; Didié M; Knöll G; Zimmermann WH; Thelen P; Bickeböller H; Maier LS; Schaper W; Schaper J; Kraft T; Tschöpe C; Linke WA; Chien KR
Circ Res; 2010 Mar; 106(4):695-704. PubMed ID: 20044516
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.
Hoffmann S; Krause T; van Geel PP; Willenbrock R; Pagel I; Pinto YM; Buikema H; van Gilst WH; Lindschau C; Paul M; Inagami T; Ganten D; Urata H
J Mol Med (Berl); 2001 Oct; 79(10):601-8. PubMed ID: 11692158
[TBL] [Abstract][Full Text] [Related]
8. Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
Huggins CE; Domenighetti AA; Pedrazzini T; Pepe S; Delbridge LM
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):186-90. PubMed ID: 14608525
[TBL] [Abstract][Full Text] [Related]
9. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure.
Arber S; Hunter JJ; Ross J; Hongo M; Sansig G; Borg J; Perriard JC; Chien KR; Caroni P
Cell; 1997 Feb; 88(3):393-403. PubMed ID: 9039266
[TBL] [Abstract][Full Text] [Related]
10. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.
Liu Q; Chen Y; Auger-Messier M; Molkentin JD
Circ Res; 2012 Apr; 110(8):1077-86. PubMed ID: 22403241
[TBL] [Abstract][Full Text] [Related]
11. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H
Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
13. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
14. In vivo epicardial force and strain characterisation in normal and MLP-knockout murine hearts.
Michaelides M; Georgiadou S; Constantinides C
Physiol Meas; 2015 Jul; 36(7):1573-90. PubMed ID: 26057415
[TBL] [Abstract][Full Text] [Related]
15. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
[TBL] [Abstract][Full Text] [Related]
16. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.
Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc.
Heineke J; Ruetten H; Willenbockel C; Gross SC; Naguib M; Schaefer A; Kempf T; Hilfiker-Kleiner D; Caroni P; Kraft T; Kaiser RA; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1655-60. PubMed ID: 15665106
[TBL] [Abstract][Full Text] [Related]
18. Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy.
Li J; Gresham KS; Mamidi R; Doh CY; Wan X; Deschenes I; Stelzer JE
Int J Cardiol; 2018 Dec; 273():168-176. PubMed ID: 30279005
[TBL] [Abstract][Full Text] [Related]
19. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
